MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds received from offering,...
Warrant issuance costs
Loss on issuance of warrants
Others
Negative Cash Flow Breakdown
Net loss
Prepaid expenses and other curre...
Unrealized loss (gain) on equity...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-7,072,124
-3,329,171
-4,074,217
-4,177,423
Depreciation and amortization
3,751
3,853
4,103
4,102
Non-cash lease adjustments
18,626
18,727
43,002
146,895
Issuance of restricted common stock for services
-
-
232,800
134,100
Vesting of restricted common stock issued for services
127,000
38,800
-
-
Stock-based compensation
285,260
262,915
198,816
452,061
Write-off of deferred offering costs
0
33,604
-
-
Accretion of discounts on available for sale debt securities, net
47
20,172
25,487
38,015
Loss on issuance of warrants
726,427
-
-
-
Warrant issuance costs
755,233
-
-
-
Change in fair value of warrant liability
2,127,379
-
-
-
Foreign currency remeasurement gain
3,550
77,286
19,488
8,912
Realized gain on redemptions of available for sale debt securities
-
-
119
-345
Realized loss on redemption of equity securities
38,962
-
49,988
72,677
Unrealized loss (gain) on equity securities
27,238
-59,451
42,592
95,906
Prepaid expenses and other current assets
363,207
49,508
-415,005
-201,223
Accounts payable and accrued expenses
461,976
-705,025
466,998
-806,921
Operating lease liabilities
-19,361
-19,463
-40,922
-51,085
Other assets
0
-10,648
-
-
Net cash flows used in operating activities
-2,940,913
-3,772,627
-2,792,113
-4,571,980
Purchase of property and equipment
-
-
1
555
Purchase of marketable securities
-
-
4,204,493
2,076,794
Redemptions of marketable securities
692,250
4,250,000
2,500,540
8,005,887
Net cash flows provided by investing activities
692,250
4,250,000
-1,703,954
5,928,538
Proceeds from the issuance of common stock under the atm sales agreement
-
-
666,208
958,339
Proceeds received from offering, net of issuance costs
3,990,814
-
-
-
Payments of offering cost related to the atm sales agreement
-
-
139,749
-
Proceeds received from stock option exercise
887
-
0
13,442
Net cash flows provided by financing activities
3,991,701
-
526,459
971,781
Effect of foreign exchange rates on cash
-664
17,585
2,960
-261
Change in cash and cash equivalents for the period
1,742,374
494,958
-3,966,648
2,328,078
Cash and cash equivalents, beginning of period
4,917,796
4,422,838
8,389,486
7,511,079
Cash and cash equivalents, end of period
6,660,170
4,917,796
4,422,838
8,389,486
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds received from
offering, net of issuance...
$3,990,814
Proceeds received from
stock option exercise
$887
Redemptions of marketable
securities
$692,250
(-95.47%↓ Y/Y)
Net cash flows
provided by financing...
$3,991,701
Net cash flows
provided by investing...
$692,250
(-89.87%↓ Y/Y)
Change in cash and cash
equivalents for the period
$1,742,374
(220.19%↑ Y/Y)
Canceled cashflow
$2,941,577
Change in fair value of
warrant liability
$2,127,379
Warrant issuance costs
$755,233
Loss on issuance of
warrants
$726,427
Accounts payable and
accrued expenses
$461,976
(-24.48%↓ Y/Y)
Stock-based compensation
$285,260
(-7.50%↓ Y/Y)
Vesting of restricted
common stock issued for...
$127,000
Realized loss on
redemption of equity...
$38,962
(-72.61%↓ Y/Y)
Non-cash lease
adjustments
$18,626
Depreciation and
amortization
$3,751
(-58.67%↓ Y/Y)
Net cash flows used
in operating...
-$2,940,913
(64.62%↑ Y/Y)
Effect of foreign
exchange rates on cash
-$664
(-102.16%↓ Y/Y)
Canceled cashflow
$4,544,614
Net loss
-$7,072,124
(20.25%↑ Y/Y)
Prepaid expenses and
other current assets
$363,207
(484.56%↑ Y/Y)
Unrealized loss (gain) on
equity securities
$27,238
(-83.73%↓ Y/Y)
Operating lease
liabilities
-$19,361
(80.37%↑ Y/Y)
Foreign currency
remeasurement gain
$3,550
(-97.26%↓ Y/Y)
Accretion of discounts on
available for sale debt...
$47
(-99.96%↓ Y/Y)
Buy us a coffee
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)